Court order

Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation

Retrieved on: 
Monday, December 5, 2022
Summons, Court order, Settlement, Court, Forest Laboratories, Hearing, District court, Teva, Plaintiff, Sun Pharma, AB, Alzheimer's disease, Merz, Upsher-Smith Laboratories, TPP Nikola Tesla, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Person, Comment, Partnership, Merz Pharma, Actavis, Laboratory, Tablet, Tobacco Master Settlement Agreement, Inwood Laboratories, Inc. v. Ives Laboratories, Inc., Wockhardt, Generic drug, Insurance, Life insurance, Memantine

The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).

Key Points: 
  • The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).
  • The settlement with Teva includes the AB-rated generic versions of Namenda IR 5 or 10 mg tablets.
  • If you are a member of one or both classes, you may comment on or object to the proposed settlements.
  • You must object to the settlements by February 3, 2023,or request to be excluded from the class by February 3, 2023.

Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation

Retrieved on: 
Thursday, December 1, 2022
Class Action Lawsuit, Professional Services, Legal, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Upsher-Smith Laboratories, Comment, Merz Pharma, Tablet, Court order, Generic, AB, Indian Residential Schools Settlement Agreement, Merz, Actavis, Sun Pharma, TPP Nikola Tesla, District court, Summons, Teva, Partnership, Court, Laboratory, Person, Forest Laboratories, Hearing, Generic drug, Insurance, Life insurance, Memantine

The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).

Key Points: 
  • The proposed settlement with the Generic Defendants includes both consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans).
  • The settlement with Teva includes the AB-rated generic versions of Namenda IR 5 or 10 mg tablets.
  • If you are a member of one or both classes, you may comment on or object to the proposed settlements.
  • You must object to the settlements by February 3, 2023, or request to be excluded from the class by February 3, 2023.

South Dakota Court Sending Class-Action Notices to Hideaway Hills Mine Collapse Victims

Retrieved on: 
Tuesday, November 29, 2022
Court order, RAPID, Black Hawk, Supreme court, Meade, South Dakota Supreme Court, Mining, Letter, Court, Practice of law

RAPID CITY, S.D., Nov. 29, 2022 /PRNewswire/ -- Homeowners in the Hideaway Hills neighborhood near Black Hawk have begun receiving legal notices providing details about a class-action lawsuit that seeks to recover damages to their homes from unstable land conditions caused by the mining operations of the state of South Dakota.

Key Points: 
  • The notices were prepared and ordered by the Meade County 4th Judicial District Court after the South Dakota Supreme Court rejected the state's petition for intermediate appeal and cleared the way for the lawsuit to move forward.
  • A copy of the Court's Order is available here: https://www.scribd.com/document/610890863/Hideaway-Hills-Order-Re-Class-... .
  • v.State of South Dakota, No.
  • The firm focuses on client service and responsiveness with bright and creative lawyers who know how to deliver.More information atfoxrothschild.com.

District Court Rejects Asetek Patent Claims And Determines CoolIT Systems Non-Infringing

Retrieved on: 
Wednesday, October 5, 2022
Adoption, LinkedIn, PTAB, Patent Trial and Appeal Board, OEM, Order, Court order, Technology, Industry, District court, Patent, Intellectual property, Prejudice, Solution, Generic drug, Asetek

CALGARY, Alberta, Oct. 5, 2022 /PRNewswire-PRWeb/ -- CoolIT Systems (CoolIT), the global leader in scalable liquid cooling technology for desktop and data centers, announced that on September 11, 2022 the United States District Court for the Northern District of California issued an Order that granted summary judgment of non-infringement for all of CoolIT's past and current products in regard to Asetek's U.S. Patent Number 8,240,362 (the '362 patent). The court also found that CoolIT's most recent pump design does not infringe either.

Key Points: 
  • CoolIT Systems and Asetek settle all outstanding litigation following Court Order that granted summary judgment of non-infringement for all of CoolIT Systems past and current products in regard to Asetek patent.
  • Following this summary judgment, CoolIT and Asetek settled all outstanding litigation between them, and CoolIT expects that the parties will soon submit a joint stipulation dismissing CoolIT's and Asetek's claims with prejudice.
  • On January 23, 2019, Asetek sued CoolIT for patent infringement regarding the aforementioned '362 patent and four additional U.S. patents, 8,245,764; 9,733,681; 10,078,354; and 10,078,355.
  • For more information about CoolIT Systems and its technology visit https://www.coolitsystems.com/ and follow @CoolIT Systems on LinkedIn.

Dicello Levitt LLC and Freed Kanner London & Millen LLC Announce a Proposed Settlement of a Class Action Involving Purchasers of Opana ER and/or its Generic Equivalent

Retrieved on: 
Wednesday, September 7, 2022
Post office box, MDL, Insurance, Class, Clerk, Hearing, District, Settlement, NOT, Fairness, Oxymorphone, AB, Part, Defendant, FORM, Person, Everett, Counsel, Client First Settlement Funding, MDL Information Systems, Court order, Lawsuit, Medicare, Claim, Plaintiff, Letter, Intention, Medicare Part D, Summons, Generic drug, Health insurance, Impax, Court

The Court has preliminarily approved the proposed settlement between the End-Payor Classes and Impax (the "Settlement").

Key Points: 
  • The Court has preliminarily approved the proposed settlement between the End-Payor Classes and Impax (the "Settlement").
  • The proposed Impax Settlement will provide for the payment of $15 million (the "Settlement Fund") to resolve the End-Payor Classes' claims against Impax.
  • The deadlines contained in this notice may be amended by Court Order, so check the Settlement website for any updates.
  • Please do not call the Court or the Clerk of the Court for information about the Impax Settlement.

Aphria Inc. Securities Class Action: Rochon Genova LLP Announces Notice of Certification and Opt-out Deadline

Retrieved on: 
Friday, August 26, 2022
Class Action Lawsuit, Professional Services, Legal, NYSE, Ontario Superior Court of Justice, CP, Class action, Time, New York justice courts, Superior court, Person, Class, TSX, Justice, Court order, Action, THE, NOT, Class Action, DO, AL, Online gambling, Private investigator, Security (finance), Aphria

For additional important information see contact information below for Rochon Genova LLP.

Key Points: 
  • For additional important information see contact information below for Rochon Genova LLP.
  • The certified class action is Vecchio Longo Consulting Services Inc. v. Aphria Inc. et al.
  • The allegations made in the Class Action have not been proven and are disputed by the Aphria Defendants.
  • As a Class Member, you will not be required to pay any costs in the event that the Class Action is unsuccessful.

APHRIA INC. SECURITIES CLASS ACTION: NOTICE OF CERTIFICATION AND OPT-OUT DEADLINE

Retrieved on: 
Friday, August 26, 2022
NYSE, Ontario Superior Court of Justice, CP, Securities Class Action, Time, New York justice courts, Person, Class, TSX, Justice, Court order, Action, NOT, Class Action, DO, AL, Online gambling, Private investigator, Security (finance), Aphria

The Ontario Superior Court of Justice has granted leave pursuant to the Ontario Securities Act and has certified a global securities class action which permits a defined group of investors (the "Class") to pursue claims againstAphria Inc. and certain of its Officers and Directors ("Aphria Defendants").

Key Points: 
  • The Ontario Superior Court of Justice has granted leave pursuant to the Ontario Securities Act and has certified a global securities class action which permits a defined group of investors (the "Class") to pursue claims againstAphria Inc. and certain of its Officers and Directors ("Aphria Defendants").
  • The certified class action is Vecchio Longo Consulting Services Inc. v. Aphria Inc. et al.
  • The allegations made in the Class Action have not been proven and are disputed bythe Aphria Defendants.
  • As a Class Member, you will not be required to pay any costs in the event that the Class Action is unsuccessful.

SANCTION OF THE SCHEME BY THE HIGH COURT

Retrieved on: 
Wednesday, June 15, 2022
Reduction of capital, Registrar of Companies, India, ISIN, Registrar, Trustee, London Stock Exchange, London, Central bank, Person, Financial Conduct Authority, Euronext Dublin, Central Bank of Ireland, Court, Court order, Knowledge, Effective date, Scheme, Company, Goodbody Stockbrokers, Ownership, PRA, Prudential Regulation Authority (United Kingdom), Sale, Irish Takeover Panel, Credit Suisse, Acquisition, Takeover, Prudential regulation, Treasury, United Kingdom, Telephone, SEPA, Registrar of Companies, Documentation, Credit Suisse International v Stichting Vestia Groep, Security (finance), Real estate, Bank, Mail, Hibernia REIT, Goodbody

The Reduction of Capital shall become effective upon registration of the Court Order and minute of reduction by the Registrar of Companies.

Key Points: 
  • The Reduction of Capital shall become effective upon registration of the Court Order and minute of reduction by the Registrar of Companies.
  • Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the scheme document published by Hibernia REIT on 27 April 2022.
  • Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction.
  • Further details in relation to Overseas Shareholders will be contained in the Scheme Document.

Miller Law LLC and Motley Rice LLC Announce Notice of Certified Litigation Class Action in In re Zetia (Ezetimibe) Antitrust Litigation

Retrieved on: 
Friday, March 11, 2022
HI, PBM, Douglas v. U.S. District Court ex rel Talk America, TO, OR, Panamanian Social Security Fund, Plan, Pharmacy benefit management, Humana, UnitedHealth Group, Providence, Rhode Island, Greater New York, Court, ME, Pharmacy, PR, RI, Defendant, Singapore, Court order, Insurance, City, Uniformed Firefighters Association, International union, Merck & Co., Ezetimibe, CA, TPP, District court, Life insurance, Health insurance, United Food and Commercial Workers

A class action lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, Norfolk Division (the "Court").

Key Points: 
  • A class action lawsuit is pending in the U.S. District Court for the Eastern District of Virginia, Norfolk Division (the "Court").
  • Plaintiffs in the lawsuit, The City of Providence Rhode Island, International Union of Operating Engineers Local 49 Health & Welfare Fund, Painters District Council No.
  • But you give up any rights to sue the Defendants separately about the same legal claims in this lawsuit.
  • If you ask to be excluded and money or benefits are later awarded in this class action lawsuit, you will not share in those.

Slate Office REIT Announces High Court Approval to Acquire C$254.8 Million Irish Entity That Owns a Portfolio of Office, Life Sciences and Lite-Industrial Real Estate in Ireland

Retrieved on: 
Thursday, January 27, 2022
Slate, Registrar, Court order, AIM, Growth, London Stock Exchange, Forward-looking statement, Euronext Dublin, TSX, Income, Knowledge, FDI, Government, Company, Registrar of Companies, Goal, Trustee, London, REIT, Scheme, Phrase, GLOBE, GMT, High Court, Real estate, Risk management

TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Slate Office REIT (TSX: SOT.UN) (the “REIT”), an owner and operator of office real estate, announces today that the Scheme of Arrangement1 in respect of the REIT’s Firm Offer2 to acquire all of the issued and outstanding shares of Yew Grove REIT plc (an Irish-incorporated real estate investment trust that is dual-listed on Euronext Dublin (Ireland) and the AIM market of the London Stock Exchange) (“Yew Grove”), for cash consideration of €1.017 per share (the "Proposed Acquisition"), together with certain related matters, were approved today by the High Court of Ireland.

Key Points: 
  • The Proposed Acquisition would see the REIT acquire a portfolio of 23 modern, fit-for-purpose properties, which are located in strong markets across Ireland.
  • Accordingly, the Scheme is expected to take effect on 7 February 2022, at which point the Proposed Acquisition will be completed.
  • About Slate Office REIT (TSX: SOT.UN)
    Slate Office REIT is an owner and operator of office real estate.
  • A number of factors could cause actual results to differ, possibly materially, from the results discussed in the forward-looking statements.